MARKET OUTLOOK
After conducting in-depth research on North America’s 3D cell culture market, the publisher has inferred that the industry will grow progressively in terms of revenue, at a CAGR of 12.13% for the forecast duration from 2019-2027.
The United States and Canada together constitute the 3D cell culture market in North America. The North American region holds the highest share in the 3D cell culture market, which can be attributed to the rise in the demand for 3D cell culture and the market expansion in the region. 3D cellular models offer more predictive results for in-vivo tests, which makes the 3D cell culture technology a better alternative to traditional cell culture.
In addition, 3D cell culturing enables drug discovery to provide greater efficacy with respect to toxicity screening of drugs, which is boosting revenues of this segment. Furthermore, the rising incidence of diseases, in spite of exemplary improvements in therapies, has raised the demand for advancements in drug discovery & development. The developing infrastructure and the presence of international funding organizations in this region have also been instrumental in enhancing the demand for 3D cell culture systems. These factors serve as the drivers for the growth of the 3D cell culture market in North America.
COMPETITIVE OUTLOOK
Few of the prime players in the 3D cell culture market are Corning Inc., Nano3D Biosciences, Inc., GE Healthcare, Merck KGaA, Becton Dickinson and Company, Lonza Group AG, and Synthecon, Incorporated.
Table of Contents
1. North America 3D Cell Culture Market – Summary
Samples
LOADING...
Companies Mentioned
A selection of companies mentioned in this report includes:
- Becton Dickinson And Company
- Tecan Group Ltd.
- Promocell Gmbh
- Corning Inc.
- NanoBiosciences, Inc.
- Biotek, Llc
- Merck Kgaa
- Emulate
- Thermo Fisher Scientific, Inc.
- Ge Healthcare
- Insphero
- Lonza Group Ag
- Vwr Corporation
Methodology
LOADING...